Furthermore, the tumor suppressive effects of the HOXB-AS3 peptide were revealed, and a low level of the HOXB-AS3 peptide was associated with worse prognosis of CRC patients [62]. The gene discussed is PDS5B; the disease is colorectal carcinoma.